APA

Elsharkawy A., Fouad R., El Akel W., El Raziky M., Hassany M., Shiha G., Said M., Motawea I., El Demerdash T., Seif S., Gaballah A., El Shazly Y., Makhlouf M. A. M., Waked I., Abdelaziz A. O., Yosry A., El Serafy M., Thursz M., Doss W. & Esmat G. (20170815). Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. : Alimentary pharmacology & therapeutics.

Chicago

Elsharkawy A, Fouad R, El Akel W, El Raziky M, Hassany M, Shiha G, Said M, Motawea I, El Demerdash T, Seif S, Gaballah A, El Shazly Y, Makhlouf M A M, Waked I, Abdelaziz A O, Yosry A, El Serafy M, Thursz M, Doss W and Esmat G. 20170815. Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. : Alimentary pharmacology & therapeutics.

Harvard

Elsharkawy A., Fouad R., El Akel W., El Raziky M., Hassany M., Shiha G., Said M., Motawea I., El Demerdash T., Seif S., Gaballah A., El Shazly Y., Makhlouf M. A. M., Waked I., Abdelaziz A. O., Yosry A., El Serafy M., Thursz M., Doss W. and Esmat G. (20170815). Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. : Alimentary pharmacology & therapeutics.

MLA

Elsharkawy A, Fouad R, El Akel W, El Raziky M, Hassany M, Shiha G, Said M, Motawea I, El Demerdash T, Seif S, Gaballah A, El Shazly Y, Makhlouf M A M, Waked I, Abdelaziz A O, Yosry A, El Serafy M, Thursz M, Doss W and Esmat G. Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. : Alimentary pharmacology & therapeutics. 20170815.